{{Drugbox
| IUPAC_name               = cyclohexylmethylhydrazine
| image                    = Cimemoxin.svg
| CAS_number               = 3788-16-7
| CAS_supplemental         = 
| ATC_prefix               = None
| ATC_suffix               = 
| PubChem                  = 71824
| ChEMBL = 2106052
| ChemSpiderID             = 64848
| C=7 | H=16 | N=2
| molecular_weight         = 128.215 g/mol
| smiles                   = NNCC1CCCCC1
| StdInChI                 = 1S/C7H16N2/c8-9-6-7-4-2-1-3-5-7/h7,9H,1-6,8H2
| StdInChIKey              = BDHMBGHSWFWYSP-UHFFFAOYSA-N
| bioavailability          = 
| protein_bound            = 
| metabolism               = 
| elimination_half-life    = 
| excretion                = 
| pregnancy_category       = 
| legal_status             = 
| routes_of_administration = 
}}

'''Cimemoxin''' ([[International Nonproprietary Name|INN]]), or '''cyclohexylmethylhydrazine''', is a [[hydrazine]] [[monoamine oxidase inhibitor]] (MAOI) [[antidepressant]] which was never marketed.<ref name="WHO2011">{{cite web | url = http://www.who.int/medicines/services/inn/StemBook_2011_Final.pdf | author = [[World Health Organization]] | title = The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances | year = 2011 | format = PDF | accessdate = 2012-05-20}}</ref>

== See also ==
* [[Monoamine oxidase inhibitor]]
* [[Hydrazine (antidepressant)]]

== References ==
{{Reflist}}

{{Antidepressants}}
{{Navboxes
| title = [[Monoamine]]rgics
| state = collapsed
| list1  = {{Adrenergics}} {{Dopaminergics}} {{Melatonergics}} {{Serotonergics}}
}}

[[Category:Antidepressants]]
[[Category:Hydrazines]]
[[Category:Monoamine oxidase inhibitors]]


{{nervous-system-drug-stub}}